The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Polling Results for CLASS I Guidelines

Any recommendations found on these pages are for education use only. Wikidoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class I Guidelines
1. Managing warfarin to an INR equal to 2.0 to 3.0 for paroxysmal or chronic atrial fibrillation or flutter is recommended, and in post MI patients when clinically indicated (e.g., atrial fibrillation, left ventricular thrombus). Class I (Level of Evidence: A)

 Antiplatelet Agents / Anticoagulants Therapy: Warfarin CLASS I Recommendation 1 should be: CLASS I CLASS IIa CLASS IIb CLASS III

2. Use of warfarin in conjunction with aspirin and/or clopidogrel is associated with an increased risk of bleeding and should be monitored closely. Class I (Level of Evidence: B)

 Antiplatelet Agents / Anticoagulants Therapy: Warfarin CLASS I Recommendation 2 should be: CLASS I CLASS IIa CLASS IIb CLASS III

3. In patients requiring warfarin, clopidogrel, and aspirin therapy, an INR of 2.0 to 2.5 is recommended with low dose aspirin (75 mg to 81 mg) and a 75 mg dose of clopidogrel. Class I (Level of Evidence: C)

 Antiplatelet Agents / Anticoagulants Therapy: Warfarin CLASS I Recommendation 3 should be: CLASS I CLASS IIa CLASS IIb CLASS III